Wang Chao, Rui Yuhua, Zhou Yi, Hu Tu, Xia Xiaobo, Jiang Jian
Eye Center of Xiangya Hospital, Central South University, Changsha, Hunan, China.
Hunan Key Laboratory of Ophthalmology, Changsha, Hunan, China.
J Ophthalmol. 2022 May 9;2022:4810103. doi: 10.1155/2022/4810103. eCollection 2022.
To evaluate the outcomes of femtosecond laser, modified capsular tension ring, and iris hook-assisted surgical treatment of lens subluxation in patients with elevated intraocular pressure (IOP).
Fifteen patients with lens subluxation and elevated IOP were enrolled in this study. All patients underwent femtosecond-laser-assisted cataract surgery/phacoemulsification/intraocular lens implantation/modified capsular tension ring (MCTR) implantation with iris hook assistance. Uncorrected visual acuity (UCVA), best corrected visual acuity (BCVA), IOP, number of glaucoma medication complications, endothelial cell density (ECD), and tilt of the lens were recorded before and after surgery. All patients were observed for 24 months postoperatively.
UCVA and BCVA increased significantly at 1 month, 6 months, 12 months, and 24 months, compared with preoperative UCVA and BCVA ( < 0.001). IOP significantly decreased at 1 month, 3 months, 6 months, 12 months, and 24 months, compared with preoperative IOP ( < 0.001). 3 patients received glaucoma medications to control IOP after surgery. All medications were discontinued at 3 months postoperatively. Conjunctival redness or hemorrhage was observed in 11 patients (73.3%); transient corneal edema was observed in 3 patients (20.0%); and posterior capsule opacification occurred in 1 patient (6.67%). The ECD and tilt of the lens are within an acceptable range.
The combined use of a femtosecond laser, MCTR, and iris hooks is an effective and safe method for treating patients with lens subluxation and elevated IOP.
评估飞秒激光、改良型囊张力环及虹膜钩辅助手术治疗眼压升高患者晶状体半脱位的效果。
本研究纳入15例晶状体半脱位且眼压升高的患者。所有患者均接受飞秒激光辅助白内障手术/超声乳化白内障吸除术/人工晶状体植入术/改良型囊张力环(MCTR)植入术并辅以虹膜钩。记录手术前后的未矫正视力(UCVA)、最佳矫正视力(BCVA)、眼压、青光眼药物并发症数量、内皮细胞密度(ECD)及晶状体倾斜度。所有患者术后观察24个月。
与术前UCVA和BCVA相比,术后1个月、6个月、12个月及24个月时UCVA和BCVA显著提高(<0.001)。与术前眼压相比,术后1个月、3个月、6个月、12个月及24个月时眼压显著降低(<0.001)。3例患者术后需使用青光眼药物控制眼压。所有药物在术后3个月停用。11例患者(73.3%)出现结膜充血或出血;3例患者(20.0%)出现短暂性角膜水肿;1例患者(6.67%)发生后囊膜混浊。ECD及晶状体倾斜度在可接受范围内。
飞秒激光、MCTR及虹膜钩联合应用是治疗晶状体半脱位且眼压升高患者的一种有效且安全的方法。